Dexcom to Acquire Nintamed

After a six-year distribution relationship, Dexcom has entered into an agreement to acquire its distributor Nintamed, the diabetes management devicemaker announced Monday.

The acquisition will advance Dexcom’s mission to strengthen global access to its continuous glucose monitoring technologies, according to company CEO Kevin Sayer.

Nintamed maintains a presence in Germany, Switzerland and Austria. — Anisa Jibrell